These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Carvedilol inhibits basal and stimulated ACE production in human endothelial cells. Saijonmaa O; Nyman T; Fyhrquist F J Cardiovasc Pharmacol; 2004 May; 43(5):616-21. PubMed ID: 15071347 [TBL] [Abstract][Full Text] [Related]
17. Carvedilol, a nonselective beta-blocker, suppresses the production of tumor necrosis factor and tissue factor by inhibiting early growth response factor-1 expression in human monocytes in vitro. Mizuochi Y; Okajima K; Harada N; Molor-Erdene P; Uchiba M; Komura H; Tsuda T; Katsuya H Transl Res; 2007 Apr; 149(4):223-30. PubMed ID: 17383596 [TBL] [Abstract][Full Text] [Related]
18. Carvedilol, a new beta-adrenoreceptor blocker, vasodilator and free-radical scavenger, exerts an anti-shock and endothelial protective effect in rat splanchnic ischemia and reperfusion. Christopher TA; Lopez BL; Yue TL; Feuerstein GZ; Ruffolo RR; Ma XL J Pharmacol Exp Ther; 1995 Apr; 273(1):64-71. PubMed ID: 7714814 [TBL] [Abstract][Full Text] [Related]